Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor

Mariangela Novello, Antonella Coli, Giuseppe Maria Della Pepa, Maurizio Martini, Francesco Doglietto, Valerio De Stefano, Silvia Bellesi, Edoardo Pescarmona, Libero Lauriola

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)


Myeloid sarcoma (MS) is a localized extra-medullary tumor mass of immature myeloid cells, arising de novo or related to acute myeloid leukemia, of which it can be a forerunner, a coinciding or late event. Less commonly, MS represents an acute blastic transformation of myelodysplastic syndromes or myeloproliferative neoplasms. This rare condition commonly consists of a proliferation of more or less immature cells with a myeloid immunophenotype, very exceptional cases showing a megakaryoblastic or erythroid differentiation. The most common localization of MS is the skin, lymph node, soft tissues and bones, but CNS involvement is exceedingly rare, with no cases reported in the sellar region. We report a 54-year-old man, affected by myeloproliferative neoplasm, JAK2 V617F-positive of 13 years duration, who acutely presented with a third cranial nerve palsy; neuroradiology documented a space-occupying lesion at the level of the sellar, upper clival and right parasellar regions, that was sub-totally removed with a trans-sphenoidal approach. The histological examination documented a proliferation of large, blastic cells, frequently multinucleated; a diagnosis of MS with megakaryoblastic differentiation, arising in a background of chronic idiopathic myelofibrosis, was suggested by immunohistochemistry, owing to CD42b, CD45, CD61 and LAT (linker for activation of T cells) positivity. In addition, homozygous JAK2 V617F mutation was detected from the myeloid sarcoma specimen. A few weeks after surgery, an acute blastic leukemic transformation occurred and, despite chemotherapy, the patient died 2 months after surgery. To the best of our knowledge, this is the first MS case with megakaryoblastic differentiation arising within the CNS.
Original languageEnglish
Pages (from-to)179-184
Number of pages6
Publication statusPublished - 2014


  • JAK2 V617F mutation
  • Pituitary Neoplasms
  • myelofibrosis
  • myeloid sarcoma


Dive into the research topics of 'Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor'. Together they form a unique fingerprint.

Cite this